In a 13‑year‑old female with hemoglobin 17.5 g/dL, hematocrit 52.6 %, RBC count 6.23 ×10⁶/µL, serum iron 103 µg/dL, total iron‑binding capacity 468 µg/dL, transferrin saturation 22 %, red cell distribution width 12.2 %, platelet count 472 ×10³/µL, vitamin B12 282 pg/mL, folate 16.6 ng/mL, and 25‑hydroxy‑vitamin D 12.2 ng/mL, what supplementation regimen is recommended?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Immediate Vitamin D Supplementation Required

This 13-year-old requires urgent vitamin D supplementation for severe deficiency (12.2 ng/mL), with a loading dose followed by maintenance therapy; her iron parameters are normal and do not require supplementation, while her B12 and folate are adequate.

Critical Finding: Severe Vitamin D Deficiency

Her vitamin D level of 12.2 ng/mL represents severe deficiency (below the 10-12 ng/mL threshold that dramatically increases risk for rickets and osteomalacia) 1. This is particularly concerning in a 13-year-old during peak bone development.

Vitamin D Treatment Protocol

Loading Phase:

  • Administer 50,000 IU vitamin D2 or D3 once weekly for 8 weeks 2
  • Alternative: Weight-adjusted loading doses can be used, though the weekly regimen is well-established

Maintenance Phase:

  • After loading: 800-2000 IU daily 1, 2
  • Target level: 30-40 ng/mL 2
  • Recheck 25(OH)D level at 3 months minimum after starting supplementation 2

Important considerations:

  • Vitamin D3 (cholecalciferol) is preferred over D2 if both available, especially for intermittent dosing 2
  • Avoid single annual bolus doses (>500,000 IU) which may cause harm 2
  • Daily or weekly dosing is safer than large infrequent boluses

Iron Status: No Supplementation Needed

Her iron parameters are normal and do not warrant supplementation:

  • Transferrin saturation 22% is above the 20% threshold for iron deficiency 3
  • Serum iron 103 µg/dL is normal
  • RDW 12.2% is normal (elevated RDW is the earliest marker of iron deficiency) 4

Why Her Labs Look Unusual

Her elevated hemoglobin (17.5 g/dL), hematocrit (52.6%), and RBC count (6.23) suggest:

  • Polycythemia (relative or absolute)
  • Possible dehydration
  • High altitude residence
  • Other causes requiring evaluation

Critical pitfall: Do NOT give iron supplementation based on TIBC alone. Her TIBC of 468 µg/dL is elevated, but this is expected when iron stores are normal-to-high and does not indicate deficiency. The transferrin saturation (22%) and normal serum iron confirm adequate iron status 3, 5.

Vitamin B12 and Folate: Adequate

  • B12 of 282 pg/mL is low-normal but adequate (typically >200 pg/mL is sufficient)
  • Folate 16.6 ng/mL is excellent
  • No supplementation needed for either

Monitoring Plan

  1. Recheck vitamin D at 3 months after starting supplementation 2
  2. Investigate polycythemia - her elevated hemoglobin/hematocrit needs evaluation for secondary causes
  3. Consider B12 monitoring if symptoms of deficiency develop, though current level is acceptable

Summary Treatment Plan

Start immediately:

  • Vitamin D: 50,000 IU weekly × 8 weeks, then 800-2000 IU daily maintenance

Do NOT supplement:

  • Iron (normal status despite elevated TIBC)
  • B12 or folate (adequate levels)

Follow-up:

  • Vitamin D level in 3 months
  • Evaluate cause of polycythemia

The elevated platelet count (472) may be reactive and should normalize with vitamin D repletion, but monitor if it persists.

Related Questions

What is the diagnosis and recommended management for a patient with increased total iron‑binding capacity, low serum iron, and low transferrin saturation?
In a 76‑year‑old woman with ferritin 20 ng/mL, hemoglobin 13.9 g/dL, transferrin saturation ~24%, mildly elevated aspartate aminotransferase (AST) and alanine aminotransferase (ALT) (40–50 U/L), intolerance to oral iron, and a history of duodenal fissures with intermittent melena, is it appropriate to proceed directly to a 1000 mg intravenous iron (IV iron) infusion?
A 13-year-old male with low ferritin, low transferrin saturation, low serum iron, and high unsaturated iron‑binding capacity—what is the diagnosis and recommended treatment?
With serum iron 49 µg/dL, transferrin saturation 13% (low), and total iron‑binding capacity 366 µg/dL (low), what is the likely diagnosis and how should I evaluate and manage the patient?
What does a serum iron of 32 µg/dL with a transferrin saturation of 12% indicate and how should it be managed?
In an infant with eczema herpeticum resistant to acyclovir, which antiviral medication should be used?
What is the evidence for intravenous immunoglobulin (IVIG) use in patients with antiphospholipid syndrome (APS)?
What is the immediate treatment for a warm‑and‑wet acute decompensated heart failure exacerbation?
Should an implantable cardioverter-defibrillator (ICD) be deactivated at the end of life?
Is foscarnet an interferon?
Is levocetirizine safe for use while breastfeeding?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.